Dilated cardiomyopathy is a clinical syndrome characterised by ventricular dilatation and associated systolic dysfunction in the absence of pericardial, valvar, or coronary artery disease.' The clinical presentation, course, and prognosis of dilated cardiomyopathy are highly variable. In most studies of the clinical presentation of dilated cardiomyopathy, embolism was identified as a frequent and serious complication of this disease.2 It is estimated that at least 11% of patients with dilated cardiomyopathy have one or more embolic events during the course of their illness.3 The timing and severity of t)iromboembolism in patients with dilated cardiomyopathy are highly variable. In some instances embolic events are clinically silent and are detected only at necropsy as peripheral infarcts in patients dying of progressive congestive heart failure. More commonly, embolism occurs long after the onset of clinical evidence of congestive heart failure. 4 In a few patients embolic events precede all other cardiac symptoms and the clinical effects of peripheral infarcts may overshadow the primary cardiac disease and confuse the diagnosis. Retrospective evaluation ofthese patients, however, has generally shown that radiographic cardiomegaly or electrocardiographic abnormalities were present at the time of embolisation.45
The systemic emboli described in patients with dilated cardiomyopathy are generally large and affect, in order of decreasing frequency, the lungs, the kidneys, the spleen, and the brain."'0 The occurrence of arterial microemboli as a presenting feature of dilated cardiomyopathy has not been reported before.
We describe a patient in whom arterial microembolisation was the presenting sign of dilated cardiomyopathy.
Case report A 37 year old white woman was admitted to the hospital with severe pain and discoloration in both fifth toes. She had been in good health 63 until a month before admission when she noticed a painless "bluish discolouration" of the left fifth toe followed by similar changes in the right fifth toe. Two weeks before admission she had severe intermittent pain in both discoloured toes particularly at night. The The left ventricular mural thrombus seen on the cross sectional echocardiogram was the only identifiable source of the patient's microemboli.
The hypothesis that emboli originate from mural thrombi that form in the cardiac chambers as the result of blood stasis secondary to severely impaired systolic function is supported by the necropsy finding of cardiac thrombi in as many as 53% of patients with dilated cardiomyopathy.'2 Other investigators have proposed that at least some embolic events in dilated cardiomyopathy are the manifestation of a generalised thrombotic tendency. This is suggested by a Japanese study of 36 patients with dilated cardiomyopathy. Four of these patients were young, suffered embolic events early in the course of their cardiac disease, which dominated the clinical picture, and died within a year of the onset of heart failure.'3 Although a hypercoagulable state could not be conclusively ruled out in our patient, the normal platelet count and normal coagulation studies make the possibility of a generalised thrombotic tendency unlikely. Another possible cause of embolism in patients with dilated cardiomyopathy is arrhythmia.7 Our patient was in normal sinus rhythm and she had no electrocardiographic evidence of intermittent atrial fibrillation or complex ventricular arrhythmias.
Some investigators reported significant alterations in the activity of mitochondrial enzymes in the myocardial biopsy samples of patients with a history of excessive alcohol intake.'4 On the basis of this finding it has been suggested that enzyme analysis of the biopsy samples may distinguish heart failure owing to alcohol from other causes of dilated cardiomyopathy. Biochemical analysis of the myocardial tissue was not performed in our patient. Three aspects of our patient's clinical picture, however, suggest that an unusual reaction to alcohol may have contributed to her cardiac dysfunction. These include a history of alcohol intake, the raised mean corpuscular volume, and the improvement of left ventricular function after she stopped drinking alcohol. Reversal of alcoholic cardiomyopathy has been previously reported by several investigators. '"' Recent experimental evidence suggests that alcohol, by altering major regulatory mechanisms in the cell, has a direct toxic effect on the myocardium.'5 '9 Thus it is possible that removal of the toxic insult improves cardiac function.
Another reversible cause of dilated cardiomyopathy is myocarditis.'9 Myocardial inflammation was not seen on the patient's endomyocardial biopsy samples and she had no prodromes attributable to a viral infection. But because the diagnostic value of an endomyocardial biopsy specimen is limited by the possibility of sampling error, spontaneous resolution ofmyocarditis cannot be excluded in our patient.20
Peripheral microemboli originating from a cardiac mural thrombus can be the presenting symptom of dilated cardiomyopathy. Thus this disease entity should be identified or ruled out in patients showing evidence of peripheral microembolisation even when there are no symptoms of congestive heart failure.
